PH11594A - Pharmaceutical compositions containing pyrimidinones and method of treating gastric hyperacidity - Google Patents

Pharmaceutical compositions containing pyrimidinones and method of treating gastric hyperacidity

Info

Publication number
PH11594A
PH11594A PH17784A PH17784A PH11594A PH 11594 A PH11594 A PH 11594A PH 17784 A PH17784 A PH 17784A PH 17784 A PH17784 A PH 17784A PH 11594 A PH11594 A PH 11594A
Authority
PH
Philippines
Prior art keywords
pyrimidinones
pharmaceutical compositions
compositions containing
treating gastric
gastric hyperacidity
Prior art date
Application number
PH17784A
Inventor
J Stam
C Lipinski
H Hess
G Deangelis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH11594A publication Critical patent/PH11594A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH17784A 1971-10-29 1975-11-21 Pharmaceutical compositions containing pyrimidinones and method of treating gastric hyperacidity PH11594A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (1)

Publication Number Publication Date
PH11594A true PH11594A (en) 1978-03-31

Family

ID=22715935

Family Applications (2)

Application Number Title Priority Date Filing Date
PH13959A PH10129A (en) 1971-10-29 1972-10-02 Pyrimidinones and hydroxy pyrimidines
PH17784A PH11594A (en) 1971-10-29 1975-11-21 Pharmaceutical compositions containing pyrimidinones and method of treating gastric hyperacidity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PH13959A PH10129A (en) 1971-10-29 1972-10-02 Pyrimidinones and hydroxy pyrimidines

Country Status (25)

Country Link
JP (2) JPS5337870B2 (en)
AR (2) AR198798A1 (en)
AT (2) AT321308B (en)
AU (1) AU467600B2 (en)
BE (1) BE790125A (en)
CA (1) CA980778A (en)
CH (2) CH549579A (en)
DE (3) DE2248741C3 (en)
DK (1) DK131465B (en)
EG (1) EG11013A (en)
ES (2) ES407730A1 (en)
FI (1) FI55503C (en)
FR (1) FR2157865B1 (en)
GB (2) GB1377720A (en)
IE (1) IE37043B1 (en)
IL (2) IL40458A (en)
LU (1) LU66304A1 (en)
NL (1) NL166470C (en)
NO (1) NO136574C (en)
PH (2) PH10129A (en)
PL (2) PL89852B1 (en)
SE (2) SE393376B (en)
SU (2) SU498908A3 (en)
YU (2) YU35125B (en)
ZA (1) ZA727362B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (en) * 1979-04-17 1980-11-01
DE3222914A1 (en) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg SUBSTITUTED 5-PHENYLTHIO-6-AMINO-PYRIMIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE, AND PREPARATIONS CONTAINING THESE COMPOUNDS
JPH0655686B2 (en) * 1988-08-30 1994-07-27 宇部興産株式会社 Process for producing p-bromophenoxyacetaldehyde dialkyl acetals
KR101452518B1 (en) 2005-08-22 2014-10-21 멜리어 파마슈티칼스 아이, 인코포레이티드 Methods and formulations for the modulation of LYN kinase activity and the treatment of related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
EP3609500B1 (en) 2017-04-10 2024-11-13 Melior Pharmaceuticals I, Inc. Treatment of adipocytes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951431A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
DE2248741C3 (en) 1975-06-26
ES436624A1 (en) 1977-02-01
NO136574C (en) 1977-09-28
SU505362A3 (en) 1976-02-28
AT321308B (en) 1975-03-25
ES407730A1 (en) 1976-01-16
NL7213959A (en) 1973-05-02
AR198798A1 (en) 1974-07-24
BE790125A (en) 1973-04-16
YU255172A (en) 1980-03-15
IE37043L (en) 1973-04-29
FI55503B (en) 1979-04-30
LU66304A1 (en) 1973-05-03
IE37043B1 (en) 1977-04-27
DE2248741B2 (en) 1974-11-14
FI55503C (en) 1979-08-10
DK131465C (en) 1975-12-08
DE2264657C2 (en) 1982-09-16
PL89852B1 (en) 1976-12-31
YU99179A (en) 1981-08-31
NO136574B (en) 1977-06-20
IL40458A0 (en) 1972-11-28
DE2264374B2 (en) 1980-08-07
YU36295B (en) 1982-06-18
GB1377308A (en) 1974-12-11
PH10129A (en) 1976-09-02
CH549579A (en) 1974-05-31
SU498908A3 (en) 1976-01-05
DK131465B (en) 1975-07-21
DE2248741A1 (en) 1973-05-03
IL48790A0 (en) 1976-03-31
AR196263A1 (en) 1973-12-10
NL166470B (en) 1981-03-16
FR2157865A1 (en) 1973-06-08
DE2264374C3 (en) 1981-07-23
AT320656B (en) 1975-02-25
SE397090B (en) 1977-10-17
DE2264657A1 (en) 1974-06-20
PL84634B1 (en) 1976-04-30
FR2157865B1 (en) 1975-10-31
JPS5422995B2 (en) 1979-08-10
JPS53116386A (en) 1978-10-11
ZA727362B (en) 1973-11-28
SE393376B (en) 1977-05-09
JPS4852780A (en) 1973-07-24
AU467600B2 (en) 1975-12-04
YU35125B (en) 1980-09-25
SE7505279L (en) 1975-05-06
IL48790A (en) 1976-05-31
JPS5337870B2 (en) 1978-10-12
AU4722872A (en) 1974-04-04
IL40458A (en) 1976-05-31
DE2264374A1 (en) 1973-05-24
GB1377720A (en) 1974-12-18
EG11013A (en) 1976-11-30
CA980778A (en) 1975-12-30
NL166470C (en) 1981-08-17
CH555832A (en) 1974-11-15

Similar Documents

Publication Publication Date Title
CS188151B2 (en) Method of organo silicon compounds containing sulphur
GB1374511A (en) Fixator for fractures of diaphyses
ZA727225B (en) Developer composition and process of using same
GB1392181A (en) Fixation of nitrogenous materials
ZA722159B (en) Method of treating sio2-dust
EG11345A (en) Method for preparation derivatives of oxadizalon and compounds containing it
GB1402930A (en) 3-aroyl-azacycloalkenes process for their manufacture and pharmaceutical preparations containing them
IL38737A0 (en) Treatment of solutions containing cyanhydrines
ZA727426B (en) Process for preservation of blood and compositions and means therefor
HU167410B (en) Process for production of 2-/amin-phenil-amin/-3-aza-1-tiacycloalcanes and medical compositions containing these compounds
ZA722672B (en) Treatment of gases
PH11940A (en) 2-amino-4-aryl-imidazolines(2)and process of preparation thereof
ZM17172A1 (en) Treatment of titanium
IL37798A0 (en) Novel fluoro-steroids of thepregnane series and pharmaceutical compositions containing them
IL39596A0 (en) Analogs of lincomycin and process
HK10476A (en) Treatment of sewage
ZA724697B (en) Thieno-diazepine derivatives and method of preparation thereof
CS164401B1 (en) Method of 1-beta-d-arabinofuranosylcytosine's preparation
KR780000067B1 (en) Preparation of n-(1-ethyl-pyrrolidinyl-2-)methyl-2-methoxy-5-sulphamoyl-benzamide
ZA724296B (en) New medicants for the treatment of excess lipidic and cellulitic stresses
ZA718319B (en) Composition of matter and method of use
CA885975A (en) Method of treating gastric hyperacidity
IL39516A0 (en) Substituted 4-propoxy-9-fluoronone compounds and pharmaceutical compositions containing them
ZA727712B (en) Process for the preparation of phosphine oxides and sulphides
ZA722016B (en) Treatment of pigments